Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1)

British Journal of Pharmacology

Volumn 144, Issue 6, 2005, Pages 781-790

  McNamara, Fergal N ^a   Randall, Andrew ^a   Gunthorpe, Martin J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Capsaicin; Electrophysiology; Ion channel; Pain; Piperine; TRPV; TRPV1; Vanilloid; VR1

Indexed keywords

CAPSAICIN; CAPSAICIN DERIVATIVE; CAPSAZEPINE; GASTROINTESTINAL AGENT; PIPERINE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 AGONIST; VANILLOID RECEPTOR 1 ANTAGONIST;

ACIDIFICATION; ARTICLE; BLACK PEPPER; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; EMBRYO; GASTROINTESTINAL TRACT FUNCTION; HUMAN; HUMAN CELL; PATCH CLAMP; PH; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TACHYPHYLAXIS;

ALKALOIDS; BENZODIOXOLES; BLACK PEPPER; CAPSAICIN; CELL LINE; HUMANS; HYDROGEN-ION CONCENTRATION; PATCH-CLAMP TECHNIQUES; PIPERIDINES; POLYUNSATURATED ALKAMIDES; RECEPTORS, DRUG; RUTHENIUM RED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 17144418518     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706040     Document Type: Article

References (54)

1. BAJAD, S., BEDI, K.L., SINGLA, A.K. & JOHRI, R.K. (2001). Antidiarrhoeal activity of pipeline in mice. Planta Med., 67, 284-287.
2. BUDAVARI, S., O'NEIL, M.J., SMITH, A. & HECKELMAN, P.E. (ed.) (1989). Merck Index, 11th edn., pp. 1186-1187. NJ, U.S.A.: Merck & Co., Inc.
3. CAPASSO, R., IZZO, A.A., BORRELLI, F., RUSSO, A., SAUTEBIN, L., PINTO, A., CAPASSO, F. & MASCOLO, N. (2002). Effect of piperine, the active ingredient of black pepper, on intestinal secretion in mice. Life Sci., 71, 2311-2317.
4. CATERINA, M.J., SCHUMACHER, M.A., TOMINAGA, M., ROSEN, T.A., LEVINE, J.D. & JULIUS, D. (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 389, 816-824.
5. CHAN, C.L., FACER, P., DAVIS, J.B., SMITH, G.D., EGERTON, J., BOUNTRA, C., WILLIAMS, N.S. & ANAND, P. (2003). Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet, 361, 385-391.
6. DEDOV, V.N., TRAN, V.H., DUKE, C.C., CONNOR, M., CHRISTIE, M.J., MANDADI, S. & ROUFOGALIS, B.D. (2002). Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br. J. Pharmacol., 137, 793-798.
7. GAWA, N.R., KLIONSKY, L., QU, Y., SHI, L., TAMIR, R., EDENSON, S., ZHANG, T.J., VISWANADHAN, V.N., TOTH, A., PEARCE, L.V., VANDERAH, T.W., PORRECA, F., BLUMBERG, P.M., LILE, J., SUN, Y., WILD, K., LOUIS, J.C. & TREANOR, J.J. (2004). Molecular Determinants of Vanilloid Sensitivity in TRPV1. J. Biol. Chem., 279, 20283-20295.
8. GEPPETTI, P. & TREVISANI, M. (2004). Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. Br. J. Pharmacol., 8, 1313-1320.
9. GREEN, B.G. (1996). Rapid recovery from capsaicin desensitization during recurrent stimulation. Pain, 68, 245-253.
10. GUNTHORPE, M.J., BENHAM, C.D., RANDALL, A. & DAVIS, J.B. (2002). The diversity in the vanilloid (TRPV) receptor family of ion channels. Trends Pharmacol. Sci., 23, 183-191.
11. GUNTHORPE, M.J., DAVIS, J.B. & RANDALL, A.D. (2004). Activation and modulation of human vanilloid receptor-1 (hTRPV1) by protons. J. Physiol., 555P, C2.
12. GUNTHORPE, M.J., HARRIES, M.H., PRINJHA, R.K., DAVIS, J.B. & RANDALL, A. (2000). Voltage- and time-dependent properties of the recombinant rat vanilloid receptor (rVR1). J. Physiol., 525, 747-749.
13. HARVEY, J.S., DAVIS, C., JAMES, I.F. & BURGESS, G.M. (1995). Activation of protein kinase C by the capsaicin analogue resiniferatoxin in sensory neurones. J. Neurochem., 65, 1309-1317.
14. HAYES, P., MEADOWS, H.J., GUNTHORPE, M.J., HARRIES, M.H., DUCKWORTH, D.M., CAIRNS, W., HARRISON, D.C., CLARKE, C.E., ELLINGTON, K., PRINJHA, R.K., BARTON, A.J., MEDHURST, A.D., SMITH, G.D., TOPP, S., MURDOCK, P., SANGER, G.J., TERRETT, J., JENKINS, O., BENHAM, C.D., RANDALL, A.D., GLOGER, I.S. & DAVIS, J.B. (2000). Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain, 88, 205-215.
15. HOLZER, P. (2004). Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets. Expert Opin. Ther. Targets, 8, 107-123.
16. HUANG, S.M., BISOGNO, T., TREVISANI, M., AL HAYANI, A., DE PETROCELLIS, L., FEZZA, F., TOGNETTO, M., PETROS, T.J., KREY, J.F., CHU, C.J., MILLER, J.D., DAVIES, S.N., GEPPETTI, P., WALKER, J.M. & DI MARZO, V. (2002). An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl Acad. Sci. U.S.A., 99, 8400-8405.
17. HWANG, S.W., CHO, H., KWAK, J., LEE, S.Y., KANG, C.J., JUNG, J., CHO, S., MIN, K.H., SUH, Y.G., KIM, D. & OH, U. (2000). Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. U.S.A., 97, 6155-6160.
18. IIDA, T., MORIYAMA, T., KOBATA, K., MORITA, A., MURAYAMA, N., HASHIZUME, S., FUSHIKI, T., YAZAWA, S., WATANABE, T. & TOMINAGA, M. (2003). TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate. Neuropharmacology, 44, 958-967.
19. IZUMI, N., MATSUYAMA, H., KO, M., SHIMIZU, Y. & TAKEWAKI, T. (2003). Role of intrinsic nitrergic neurones on vagally mediated striated muscle contractions in the hamster oesophagus. J. Physiol., 551, 287-294.
20. IZZO, A.A., CAPASSO, R., PINTO, L., DI CARLO, G., MASCOLO, N. & CAPASSO, F. (2001). Effect of vanilloid drugs on gastrointestinal transit in mice. Br. J. Pharmacol., 132, 1411-1416.
21. JERMAN, J.C., BROUGH, S.J., PRINJHA, R., HARRIES, M.H., DAVIS, J.B. & SMART, D. (2000). Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology. Br. J. Pharmacol., 130, 916-922.
22. JORDT, S.E. & JULIUS, D. (2002). Molecular basis for species-specific sensitivity to 'hot' chili peppers. Cell, 108, 421-430.
23. JORDT, S.E., TOMINAGA, M. & JULIUS, D. (2000). Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc. Natl. Acad. Sci U.S.A. 97, 8134-8139.
24. KEDEI, N., SZABO, T., LILE, J.D., TREANOR, J.J., OLAH, Z., IADAROLA, M.J. & BLUMBERG, P.M. (2001). Analysis of the native quaternary structure of vanilloid receptor 1. J. Biol. Chem., 276, 28613-28619.
25. KOPLAS, P.A., ROSENBERG, R.L. & OXFORD, G.S. (1997). The role of calcium in the desensitization of capsaicin responses in rat dorsal root ganglion neurons. J. Neurosci., 17, 3525-3537.
26. LIU, L. & SIMON, S.A. (1996a). Similarities and differences in the currents activated by capsaicin, piperine, and zingerone in rat trigeminal ganglion cells. J. Neurophysiol., 76, 1858-1869.
27. 2+ dependence in rat trigeminal ganglion cells. J. Neurophysiol., 75, 1503-1514.
28. LIU, L., WELCH, J.M., ERICKSON, R.P., REINHART, P.H. & SIMON, S.A. (2000). Different responses to repeated applications of zingerone in behavioral studies, recordings from intact and cultured TG neurons, and from VR1 receptors. Physiol. Behav., 69, 177-186.
29. MARSHALL, I.C., OWEN, D.E., CRIPPS, T.V., DAVIS, J.B., MCNULTY, S. & SMART, D. (2003). Activation of vanilloid receptor 1 by resiniferatoxin mobilizes calcium from inositol 1,4,5-trisphosphate-sensitive stores. Br. J. Pharmacol, 138, 172-176.
30. MCNAMARA, F., RANDALL, A.D. & GUNTHORPE, M.J. (2004). The effects of Piperine, the pungent ingredient of black pepper, at the human vanilloid receptor (hTRPV1). J. Physiol., 555P, C1.
31. NAIDU, K.A. & THIPPESWAMY, N.B. (2002). Inhibition of human low density lipoprotein oxidation by active principles from spices. Mol. Cell Biochem., 229, 19-23.
32. NOCERINO, E, IZZO, AA, BORRELLI, F, CAPASSO, F, CAPASSO, R, PINTO, A, SAUTEBIN, L & MASCOLO, N. (2002). Relaxant effect of capsazepine in the isolated rat ileum. Naunyn. Schmiedebergs Arch. Pharmacol., 365, 187-192.
33. PATACCHINI, R., MAGGI, C.A. & MELI, A. (1990). Capsaicin-like activity of some natural pungent substances on peripheral endings of visceral primary affrerents. Naunyn. Schmiedebergs Arch. Pharmacol., 342, 72-77.
34. PATTERSON, L.M., ZHENG, H., WARD, S.M. & BERTHOUD, H.R. (2003). Vanilloid receptor (VR1) expression in vagal afferent neurons innervating the gastrointestinal tract. Cell Tissue Res., 311, 277-287.
35. RIBEIRO, T.S., FREIRE-DE-LIMA, L., PREVIATO, J.O., MENDONCA-PREVIATO, L., HEISE, N. & DE LIMA, M.E. (2004). Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi. Bioorg. Med. Chem. Lett., 14, 3555-3558.
36. ROSS, R.A., GIBSON, T.M., BROCKIE, H.C., LESLIE, M., PASHMI, G., CRAIB, S.J., DI, M.V. & PERTWEE, R.G. (2001). Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br. J. Pharmacol., 132, 631-640.
37. RYU, S., LIU, B. & QIN, F. (2003). Low pH potentiates both capsaicin binding and channel gating of VR1 receptors. J. Gen. Physiol., 122, 45-61.
38. SCHICHO, R., FLORIAN, W., LIEBMANN, I., HOLZER, P. & LIPPE, I.T. (2004). Increased expression of TRPV1 receptor in dorsal root ganglia by acid insult of the rat gastric mucosa. Eur. J. Neurosci., 19, 1811-1818.
39. SMART, D., GUNTHORPE, M.J., JERMAN, J.C., NASIR, S., GRAY, J., MUIR, A.I., CHAMBERS, J.K., RANDALL, A.D. & DAVIS, J.B. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol., 129, 227-230.
40. SMART, D., JERMAN, J.C., GUNTHORPE, M.J., BROUGH, S.J., RANSON, J., CAIRNS, W., HAYES, P.D., RANDALL, A.D. & DAVIS, J.B. (2001). Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur. J. Pharmacol., 417, 51-58.
41. STERNER, O. & SZALLASI, A. (1999). Novel natural vanilloid receptor agonists: new therapeutic targets for drug development. Trends Pharmacol. Sci., 20, 459-465.
42. SZALLASI, A. & APPENDINO, G. (2004). Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse? J. Med. Chem., 47, 2717-2723.
43. SZALLASI, A. & BLUMBERG, P.M. (1991). Characterization of vanilloid receptors in the dorsal horn of pig spinal cord. Brain Res., 547, 335-338.
44. SZALLASI, A. & BLUMBERG, P.M. (1999). Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev., 51, 159-212.
45. SZOLCSANYI, J. (1983). Tetrodotoxin-resistant non-cholinergic neurogenic contraction evoked by capsaicinoids and piperine on the guinea-pig trachea. Neurosci. Lett., 42, 83-88.
46. SZOLCSANYI, J. & BARTHO, L. (2001). Capsaicin-sensitive afferents and their role in gastroprotection: an update. J. Physiol. Paris, 95, 181-188.
47. SZOLCSANYI, J. & JANCSO-GABOR, A. (1975). Sensory effects of capsaicin congeners I. Relationship between chemical structure and pain-producing potency of pungent agents. Arzneimittelforschung, 25, 1877-1881.
48. TOMINAGA, M., CATERINA, M.J., MALMBERG, A.B., ROSEN, T.A., GILBERT, H., SKINNER, K., RAUMANN, B.E., BASBAUM, A.I. & JULIUS, D. (1998). The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron, 21, 531-543.
49. VAN DER STELT, M. & DI MARZO, V. (2004). Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur. J. Biochem., 271, 1827-1834.
50. VIJAYAKUMAR, R.S., SURYA, D. & NALINI, N. (2004). Antioxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress. Redox. Rep., 9, 105-110.
51. WARD, S.M., BAYGUTNOV, J., WON, K.J., GRUNDY, D. & BERTHOUD, H.R. (2003). Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract. J. Comp. Neurol., 465, 121-135.
52. WELCH, J.M., SIMON, S.A. & REINHART, P.H. (2000). The activation mechanism of rat vanilloid receptor 1 by capsaicin involves the pore domain and differs from the activation by either acid or heat. Proc. Natl. Acad. Sci. U.S.A., 97, 13889-13894.
53. YIANGOU, Y., FACER, P., DYER, N.H., CHAN, C.L., KNOWLES, C., WILLIAMS, N.S. & ANAND, P. (2001). Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet, 357, 1338-1339.
54. ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SORGARD, M., DI MARZO, V., JULIUS, D. & HOGESTATT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-457.